07:00 , Jun 11, 2012 |  BC Week In Review  |  Company News

Arte, ProJect Pharmaceutics deal

Japanese pharmaceutical glass packaging systems manufacturer Arte partnered with ProJect, a German developer of filling and freeze-drying processes, to develop a lyophilized dual chamber prefillable syringe (Lyo- DCPS ) for use with freeze-dried pharmaceuticals. The...
07:00 , Mar 15, 2010 |  BioCentury  |  Finance

Ebb & Flow

Israeli life sciences investment group Clal Biotechnology Industries has acquired another Israeli VC, Biomedical Investments, for NIS84 million ($23 million), of which $7.5 million was cash, along with 3 million shares and 1.25 million warrants....
08:00 , Dec 8, 2008 |  BC Week In Review  |  Company News

Anika, Artes sales and marketing update

Anika ended a July deal under which Artes became the exclusive distributor of Anika's Elevess to U.S. dermatologists, plastic surgeons and cosmetic surgeons. Anika will service customers itself while it seeks a new U.S. distribution...
08:00 , Nov 17, 2008 |  BC Week In Review  |  Company News

Artes dermatology news

Artes hired JMP Securities LLC to explore strategic alternatives while the company continues to seek equity and debt transactions to raise money. Artes markets ArteFill , polymethylmethacrylate (PMMA) microspheres suspended in ultra-purified U.S. bovine collagen...
07:00 , Oct 27, 2008 |  BC Week In Review  |  Clinical News

ArteFill: Post-marketing study completed enrollment

Artes completed enrollment of 1,000 patients in a 5-year, U.S. post-marketing study of ArteFill. The product was approved for the indication by FDA in October 2006. Artes Medical Inc. (NASDAQ:ARTE), San Diego, Calif.   Product:...
07:00 , Sep 22, 2008 |  BC Week In Review  |  Company News

Artes management update

Artes Medical Inc. (NASDAQ:ARTE), San Diego, Calif.   Business: Dermatology   Promoted: Michael Green to COO while remaining CFO  ...
07:00 , Jul 14, 2008 |  BC Week In Review  |  Company News

Anika, Artes sales and marketing update

Artes will exclusively distribute Anika's Elevess in the U.S. The hyaluronic acid-based injectable temporary dermal filler with lidocaine is used to treat facial wrinkles. Artes will sell and market the product to dermatologists, plastic surgeons...
07:00 , Jun 16, 2008 |  BC Week In Review  |  Clinical News

ArteColl update

Researchers began a U.S. clinical trial in 10 patients to compare ArteFill injected subdermally throughout the metatarsal area of 1 foot vs. no treatment in the other foot. The study is being sponsored by Artes....
07:00 , Jun 2, 2008 |  BC Week In Review  |  Company News

Artes board of directors update

Artes Medical Inc. (NASDAQ:ARTE), San Diego, Calif.   Business: Dermatology   Appointed: Douglas Abel, president and CEO of Manhattan Pharmaceuticals Inc.  ...
07:00 , May 19, 2008 |  BC Week In Review  |  Company News

Artes management update

Artes Medical Inc. (NASDAQ:ARTE), San Diego, Calif.   Business: Dermatology   Resigned: Diane Goostree as president, CEO and a director  ...